251 related articles for article (PubMed ID: 10897331)
1. Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours.
Korneyev IA; Mamaev NN; Kozlov VV; Rybakova MG; al-Shukri SH
Mol Pathol; 2000 Jun; 53(3):129-32. PubMed ID: 10897331
[TBL] [Abstract][Full Text] [Related]
2. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
[TBL] [Abstract][Full Text] [Related]
3. Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors.
Helpap B; Loesevitz L; Bulatko A
Virchows Arch; 1994; 425(3):265-9. PubMed ID: 7812512
[TBL] [Abstract][Full Text] [Related]
4. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
[TBL] [Abstract][Full Text] [Related]
6. AgNOR counts and histological grade in stage pTa bladder tumours: reproducibility and relation to recurrence pattern.
Hansen AB; Bjerregaard B; Ovesen H; Horn T
Histopathology; 1992 Mar; 20(3):257-62. PubMed ID: 1563712
[TBL] [Abstract][Full Text] [Related]
7. Comparison of argyrophilic nucleolar organizer regions (AgNORs) and mitotic index in distinguishing benign from malignant canine smooth muscle tumors and in separating inflammatory hyperplasia from neoplastic lesions of the urinary bladder mucosa.
Johnson GC; Miller MA; Ramos-Vara JA
J Vet Diagn Invest; 1995 Jan; 7(1):127-36. PubMed ID: 7779947
[TBL] [Abstract][Full Text] [Related]
8. AgNORs in benign, borderline and transitional cell neoplasms of the urinary bladder.
Misra V; Mukherjee J; Gupta SC; Tandon S; Gupta AK
APMIS; 1998 Oct; 106(10):987-92. PubMed ID: 9833702
[TBL] [Abstract][Full Text] [Related]
9. Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer.
Lipponen PK; Eskelinen MJ; Nordling S
Br J Cancer; 1991 Dec; 64(6):1139-44. PubMed ID: 1764378
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of argyrophilic organizer region in bladder transitional cell carcinoma.
Shiina H; Shirakawa H; Yokogi H; Kishi H; Mizutani M; Igawa M; Ishibe T
Urol Int; 1995; 54(2):74-9. PubMed ID: 7747363
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of interphase argyrophilic nucleolar organiser regions in transitional cell bladder tumours.
Metze K; Cia EM; Trevisan MA
Mol Pathol; 2001 Jun; 54(3):200. PubMed ID: 11376137
[No Abstract] [Full Text] [Related]
12. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
[TBL] [Abstract][Full Text] [Related]
13. Relationship between interphase AgNOR distribution and nucleolar size in cancer cells.
Derenzini M; Farabegoli F; Trerè D
Histochem J; 1992 Dec; 24(12):951-6. PubMed ID: 1283387
[TBL] [Abstract][Full Text] [Related]
14. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters.
Skopelitou A; Korkolopoulou P; Papanicolaou A; Christodoulou P; Thomas-Tsagli E; Pavlakis K
Eur Urol; 1992; 22(3):235-40. PubMed ID: 1361436
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric DNA studies and AgNOR counts in patients with transitional cell carcinoma of the bladder.
Celikel C; Dillioğlugil O; Türkeri LN; Başaran M; Yalçiner A; Küllü S; Akdaş A
Eur Urol; 1995; 28(2):152-7. PubMed ID: 8529742
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of nucleolar organizer regions in human bladder cancers by light- and electron-microscopic morphometry.
Shimazui T; Uchiyama Y; Uchida K; Hattori K; Takahashi A; Akaza H; Koiso K
Eur Urol; 1998; 34(5):441-7. PubMed ID: 9803008
[TBL] [Abstract][Full Text] [Related]
17. Lack of prognostic value of nucleolar organizer region enumeration in transitional cell carcinoma of the bladder.
Mansour P; Crocker J; Newman J
Arch Pathol Lab Med; 1990 Dec; 114(12):1261. PubMed ID: 1701296
[TBL] [Abstract][Full Text] [Related]
18. Argyrophilic nucleolar organiser regions in transitional cell bladder tumours related to established prognostic factors, progression and independent prognostic value.
Lipponen PK; Eskelinen MJ
Oncology; 1992; 49(2):133-8. PubMed ID: 1574249
[TBL] [Abstract][Full Text] [Related]
19. [Argentophilic nucleolar organizers and prognosis for patients with surface and locally advanced transitional cell cancer of the urinary bladder].
Korneev IA
Urologiia; 2005; (1):5-9. PubMed ID: 15776823
[TBL] [Abstract][Full Text] [Related]
20. Argyrophilic nucleolar organizer region counts predict survival in thymoma.
Pich A; Chiarle R; Chiusa L; Palestro G
Cancer; 1994 Sep; 74(5):1568-74. PubMed ID: 7520349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
